$MOBQ 4 SEC Filings

Filed On	Filing
02 Jan 2026	Form 4: Trepeta Sean, Director Granted 100,000 Common Stock Options
02 Jan 2026	Form 4: Salkind Gene, Director Granted 250,000 Common Stock Options
02 Jan 2026	Form 4: Provost Anne Schmidt, Director Granted 50,000 Common Stock Options
02 Jan 2026	Form 4: McDonnell Sean, CFO Granted 100,000 Common Stock Options
02 Jan 2026	Form 4: Knight Nate, Director Granted 50,000 Common Stock Options
02 Jan 2026	Form 4: Julia Dean L., Director Granted 350,000 Common Stock Options
02 Jan 2026	Form 4: Booker Stuart Byron, Director Granted 50,000 Common Stock Options
02 Jan 2026	Form 4: Bauersfeld Paul, Chief Technology Officer Granted 100,000 Common Stock Options
19 Sep 2025	Form 4: Salkind Gene, Director Received 25,000 shares as a grant or award ($25K) · Granted 100,000 Convertible notes
02 Jan 2025	Form 4: Salkind Gene, Director Received 420,000 shares by exercise ($210K)
21 Oct 2024	Form 4: Bauersfeld Paul, Chief Technology Officer Granted 150,000 Common Stock Options
21 Oct 2024	Form 4: Julia Dean L., Director Granted 450,000 Common Stock Options
21 Oct 2024	Form 4: Provost Anne Schmidt, Director Granted 50,000 Common stock options
21 Oct 2024	Form 4: Knight Nate, Director Granted 50,000 Common stock options
21 Oct 2024	Form 4: McDonnell Sean, CFO Granted 50,000 Common Stock Options
21 Oct 2024	Form 4: Trepeta Sean, Director Granted 100,000 Common Stock Options
21 Oct 2024	Form 4: Salkind Gene, Director Granted 250,000 Common Stock Options
21 Oct 2024	Form 4: Booker Stuart Byron, Director Granted 50,000 Common stock options
08 Aug 2024	Form 4: Salkind Gene, Director Received 7,675,160 shares by conversion ($1.54M)
29 Jul 2024	Form 4: Salkind Gene, Director Granted 50,000 Convertible Promissory Notes

Comments